Call 08046040615 43% Response Rate

our range

COVID

Providing you the best range of molnupiravir 200 mg (molaz), methylene blue injection usp and molnupiravir (movfor capsule) with effective & timely delivery.
  • Molnupiravir 200 Mg (Molaz)
  • Molnupiravir 200 Mg (Molaz)
  • Molnupiravir 200 Mg (Molaz)
Molnupiravir 200 Mg (Molaz)

Molnupiravir 200 Mg (Molaz)

Rs 2,999  / BottleGet Best Price

Minimum Order Quantity: 500 Bottle

Product Brochure

Strength200MG
Packaging Size1*40
CompositionMOLNUPIRAVIR 200
TreatmentCOVID
FormTablet
BrandMOLAZ 200MG CAPSULES
ManufacturerAZISTA
Shelf life2 YEAR
Molnupiravir is an experimental antiviral drug which is orally active and was developed for the treatment of influenza. It is a prodrug of the synthetic nucleoside derivative N4-hydroxycytidine, and exerts its antiviral action through introduction of copying errors during viral RNA replication.

Additional Information:

  • Delivery Time: UP TO 15 DAYS

View Complete details

get quote request a call back
  • Methylene Blue Injection USP
  • Methylene Blue Injection USP
  • Methylene Blue Injection USP
Methylene Blue Injection USP

Methylene Blue Injection USP

Rs 6,999  / PIECEGet Best Price

Minimum Order Quantity: 10 PIECE

Product Brochure

BrandBLUEJET
Brand NameMETHYLENE BLUE
ManufacturerVULCAN LABORATORIES PVT.LTD
Packaging Type10*10
CompositionMethylene blue
Packaging Size10ml*10 Ampoules
Shelf Life2-3 YEAR
Country of OriginMade in India
Methylene Blue Injection is a prescription medicine used to treat the symptoms of Acquired Methemoglobinemia. Methylene Blue may be used alone or with other medications

Additional Information:

  • Production Capacity: 5000
  • Delivery Time: IN 7 DAYS
  • Packaging Details: 10*10

View Complete details

get quote request a call back
  • Molnupiravir (Movfor Capsule)
  • Molnupiravir (Movfor Capsule)
  • Molnupiravir (Movfor Capsule)
Molnupiravir (Movfor Capsule)

Molnupiravir (Movfor Capsule)

Rs 2,999  / BottleGet Best Price

Minimum Order Quantity: 10 Bottle

Product Brochure

Strength200mg
FormCapsules
BrandMovfor
Packaging Size1*40
ManufacturerHetero Healthcare
CompositionMolnupiravir (200mg)
TreatmentHetero Healthcare Limited
Prescription/Non prescriptionPrescription
Packaging TypeBOX
Shelf life3YEAR
Therapeutic UsesTreatment of Mild to moderate Coronavirus disease (COVID-19)
Country of OriginMade in India
Movfor Capsule is the first oral antiviral medication that helps treat mild to moderate COVID-19 in adults. It prevents the virus from multiplying, thereby reducing viral load and disease severity. The drug received emergency use approval from Indian drug regulatory authorities on December 28, 2021.

Movfor Capsule is only indicated in patients with mild to moderate COVID-19 symptoms and who have a high risk of developing severe symptoms. The risk factors include obesity, older age (>60 years), diabetes mellitus, and heart diseases. It is not indicated in patients who require immediate hospitalization due to COVID-19. This drug has also been approved by the U.S. Food and Drug Administration (FDA) and the UK regulatory agency for emergency use.

Movfor Capsule should be taken orally for no longer than 5 consecutive days. It is important to complete the entire 5 days of treatment, therefore do not stop taking it even if you feel better. The medicine may cause dizziness, headache, diarrhea, and nausea in some patients. If one experiences any such side effects, discuss them with the doctor. They may help with the treatment or suggest ways to prevent them.

Before taking Movfor Capsule, let the doctor know if you have any pre-existing medical conditions. To make sure it is safe for you, inform your doctor about all the other medications you are taking. The use of Movfor Capsule is not recommended in pregnant women. Pregnant and breastfeeding women should consult with their doctors before taking this medicine.

Additional Information:

  • Delivery Time: IN 7 DAYS
  • Packaging Details: 1*40

View Complete details

get quote request a call back

EXPLORE MORE CATEGORIES